Orange Book product · Generic (ANDA)
ZONISAMIDE
ZONISAMIDE
At a glance
Jan 26, 2021
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jan 26, 2021
5 yr 6 mo ago
Today
Pharmaceutical detail
Active ingredient
ZONISAMIDE
Strength
25MG
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
ANDA 214492
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ZONISAMIDE
- 2022ZONISADEBrand (NDA)
NDA 214273 · AZURITY
- 2003ZONEGRANBrand (NDA)
NDA 020789 · ADVANZ PHARMA
- 2025ZONISAMIDEGeneric (ANDA)
ANDA 219507 · MACLEODS PHARMS LTD
- 2007ZONISAMIDEGeneric (ANDA)
ANDA 077876 · EPIC PHARMA LLC
- 2006ZONISAMIDEGeneric (ANDA)
ANDA 077625 · ZYDUS LIFESCIENCES
- 2006ZONISAMIDEGeneric (ANDA)
ANDA 077645 · AUROBINDO PHARMA LTD
- 2006ZONISAMIDEGeneric (ANDA)
ANDA 077813 · BIONPHARMA
- 2006ZONISAMIDEGeneric (ANDA)
ANDA 077636 · GRANULES
- 2006ZONISAMIDEGeneric (ANDA)
ANDA 077869 · INVAGEN PHARMS
- 2006ZONISAMIDEGeneric (ANDA)
ANDA 077650 · CHARTWELL RX
- 2006ZONISAMIDEGeneric (ANDA)
ANDA 077634 · SUN PHARM INDS (IN)
- 2006ZONISAMIDEGeneric (ANDA)
ANDA 077651 · GLENMARK PHARMS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
